Registry of Lobbyists
Version 1 of 1 (2002-12-04 to 2004-01-28) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
PFIZER CANADA INC
17,300 TRANS-CANADA HIGHWAY KIRKLAND, QC H9J 2M5 Canada |
||||
| Telephone number: | 450-655-3359 | ||||
| Fax number: | 450-655-7370 | ||||
| Responsible officer name and position during the period of this registration: | DENISE CLOUTIER, ASSISTANT DIRECTOR, PATIENT ACCESS AND HEALTH POLI | ||||
| Description of activities: | RESEARCH, DEVELOPMENT, MANUFACTURING AND SALES OF PHARMACEUTICAL AND HEALTH CARE PRODUCTS | ||||
| The client is a subsidiary of the following parent companies: |
PFIZER INC
235 EAST 42ND STREET NEW YORK, NY United States of America 10017-5755 |
||||
| Coalition | The corporation is not a member of a coalition. | ||||
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. | ||||
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. | ||||
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | Yes | ||||
| End date of the corporation's last completed financial year: | 2001-11-30 | ||||
|
|||||
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, MEMBERS OF PARLIAMENT, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Other types: INFORMATION COMMUNICATIONS, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Health, Industry, Intellectual Property, Internal Trade, International Trade, Science and Technology |
| Subject Matter: Particulars: | PATENT PROTECTION FOR PHARMACEUTICALS PRICES FOR PHARMACEUTICALSPHARMACEUTICAL REGULATORY APPROVALS |